PT Charlie Hospital Semarang Tbk (ISX:RSCH) ROE %: 0.00% (As of . 20)


What is PT Charlie Hospital Semarang Tbk ROE %?

PT Charlie Hospital Semarang Tbk ISX:RSCH +3.55% ROE % is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 626 Healthcare Providers & Services companies, PT Charlie Hospital Semarang Tbk ranks worse than 159744.25% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. PT Charlie Hospital Semarang Tbk's annualized net income for the quarter that ended in . 20 was Rp Mil. PT Charlie Hospital Semarang Tbk's average Total Stockholders Equity over the quarter that ended in . 20 was Rp Mil. Therefore, PT Charlie Hospital Semarang Tbk's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for PT Charlie Hospital Semarang Tbk's ROE % or its related term are showing as below:

ISX:RSCH's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.805
* Ranked among companies with meaningful ROE % only.

PT Charlie Hospital Semarang Tbk  (ISX:RSCH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

PT Charlie Hospital Semarang Tbk ROE % Related Terms

PT Charlie Hospital Semarang Tbk ROE % Historical Data

* Premium members only.

The historical data trend for PT Charlie Hospital Semarang Tbk's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Charlie Hospital Semarang Tbk ROE % Chart

PT Charlie Hospital Semarang Tbk Annual Data
Trend
ROE %

PT Charlie Hospital Semarang Tbk Semi-Annual Data
ROE %

ISX:RSCH vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, PT Charlie Hospital Semarang Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Charlie Hospital Semarang Tbk ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Charlie Hospital Semarang Tbk's ROE % distribution charts can be found below:

* The bar in red indicates where PT Charlie Hospital Semarang Tbk's ROE % falls into.


PT Charlie Hospital Semarang Tbk ROE % Calculation

PT Charlie Hospital Semarang Tbk's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

PT Charlie Hospital Semarang Tbk's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a ROE % of 0.00% as of . 20. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. According to the industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 626 companies in the Healthcare Providers & Services industry.
Is PT Charlie Hospital Semarang Tbk's ROE % too high?
PT Charlie Hospital Semarang Tbk's current ROE % is 0.00%. Based on the distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 626 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does PT Charlie Hospital Semarang Tbk's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 626 companies for ROE %. This places PT Charlie Hospital Semarang Tbk in the lower half of its industry. The industry median ROE % is 5.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Charlie Hospital Semarang Tbk's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Charlie Hospital Semarang Tbk stock overvalued right now?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a current ROE % of 0.00%. The current ROE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For PT Charlie Hospital Semarang Tbk (ISX:RSCH), the current ROE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Charlie Hospital Semarang Tbk Business Description

Address Raya Ngabean Road, Lot 1A, Ngabean Village, Boja District, Kendal Regency, Central Java, Jawa, IDN, 51381
PT Charlie Hospital Semarang Tbk is engaged in private hospital activities with type D hospital qualifications located in Kendal Regency. It provides medical facilities, such as a 24-hour emergency room, Specialist Polyclinic services, Central Surgical Installation, Intensive Care Unit (ICU), Perina, Laboratory, Radiology, Pharmacy, and other supporting facilities. It operates in three segments, namely Hospital service consist of medical goods and services provided to out patients and inpatients. Construction materials trading and Construction activities include services rendered on a fee or contract basis, as well as the construction, maintenance, or reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings.